287 related articles for article (PubMed ID: 34770947)
1. Homocystamide Conjugates of Human Serum Albumin as a Platform to Prepare Bimodal Multidrug Delivery Systems for Boron Neutron Capture Therapy.
Popova T; Dymova MA; Koroleva LS; Zakharova OD; Lisitskiy VA; Raskolupova VI; Sycheva T; Taskaev S; Silnikov VN; Godovikova TS
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770947
[TBL] [Abstract][Full Text] [Related]
2. Human Serum Albumin Labelling with a New BODIPY Dye Having a Large Stokes Shift.
Raskolupova VI; Popova TV; Zakharova OD; Nikotina AE; Abramova TV; Silnikov VN
Molecules; 2021 May; 26(9):. PubMed ID: 34063643
[TBL] [Abstract][Full Text] [Related]
3. Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy.
Kikuchi S; Kanoh D; Sato S; Sakurai Y; Suzuki M; Nakamura H
J Control Release; 2016 Sep; 237():160-7. PubMed ID: 27422608
[TBL] [Abstract][Full Text] [Related]
4. Rational Design of Albumin Theranostic Conjugates for Gold Nanoparticles Anticancer Drugs: Where the Seed Meets the Soil?
Popova TV; Pyshnaya IA; Zakharova OD; Akulov AE; Shevelev OB; Poletaeva J; Zavjalov EL; Silnikov VN; Ryabchikova EI; Godovikova TS
Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33451058
[TBL] [Abstract][Full Text] [Related]
5. Cyclic RGD-Functionalized
Kawai K; Nishimura K; Okada S; Sato S; Suzuki M; Takata T; Nakamura H
Mol Pharm; 2020 Oct; 17(10):3740-3747. PubMed ID: 32845640
[TBL] [Abstract][Full Text] [Related]
6. Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model.
Kashiwagi H; Kawabata S; Yoshimura K; Fukuo Y; Kanemitsu T; Takeuchi K; Hiramatsu R; Nishimura K; Kawai K; Takata T; Tanaka H; Watanabe T; Suzuki M; Miyatake SI; Nakamura H; Wanibuchi M
Invest New Drugs; 2022 Apr; 40(2):255-264. PubMed ID: 34816337
[TBL] [Abstract][Full Text] [Related]
7. Intracellular target delivery of cell-penetrating peptide-conjugated dodecaborate for boron neutron capture therapy (BNCT).
Nakase I; Katayama M; Hattori Y; Ishimura M; Inaura S; Fujiwara D; Takatani-Nakase T; Fujii I; Futaki S; Kirihata M
Chem Commun (Camb); 2019 Nov; 55(93):13955-13958. PubMed ID: 31617510
[TBL] [Abstract][Full Text] [Related]
8. Tumor Cell-Specific 2'-Fluoro RNA Aptamer Conjugated with
Vorobyeva MA; Dymova MA; Novopashina DS; Kuligina EV; Timoshenko VV; Kolesnikov IA; Taskaev SY; Richter VA; Venyaminova AG
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298946
[TBL] [Abstract][Full Text] [Related]
9. Spermidinium closo-dodecaborate-encapsulating liposomes as efficient boron delivery vehicles for neutron capture therapy.
Tachikawa S; Miyoshi T; Koganei H; El-Zaria ME; Viñas C; Suzuki M; Ono K; Nakamura H
Chem Commun (Camb); 2014 Oct; 50(82):12325-8. PubMed ID: 25182569
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in the syntheses and biological evaluation of boronated porphyrins for boron neutron-capture therapy.
Renner MW; Miura M; Easson MW; Vicente MG
Anticancer Agents Med Chem; 2006 Mar; 6(2):145-57. PubMed ID: 16529537
[TBL] [Abstract][Full Text] [Related]
11. Design of the New
Raskolupova VI; Wang M; Dymova MA; Petrov GO; Shchudlo IM; Taskaev SY; Abramova TV; Godovikova TS; Silnikov VN; Popova TV
Molecules; 2023 Mar; 28(6):. PubMed ID: 36985644
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of phosphorous-containing derivatives of dodecahydro-closo-dodecaborate for boron neutron capture therapy of gliomas and sarcomas.
Tjarks W; Barth RF; Rotaru JH; Adams DM; Yang W; Kultyshev RG; Forrester J; Barnum BA; Soloway AH; Shore SG
Anticancer Res; 2001; 21(2A):841-6. PubMed ID: 11396173
[TBL] [Abstract][Full Text] [Related]
13. New functionalized mercaptoundecahydrododecaborate derivatives for potential application in boron neutron capture therapy: synthesis, characterization and dynamic visualization in cells.
Genady AR; Ioppolo JA; Azaam MM; El-Zaria ME
Eur J Med Chem; 2015 Mar; 93():574-83. PubMed ID: 25748122
[TBL] [Abstract][Full Text] [Related]
14. Dodecaborate lipid liposomes as new vehicles for boron delivery system of neutron capture therapy.
Ueno M; Ban HS; Nakai K; Inomata R; Kaneda Y; Matsumura A; Nakamura H
Bioorg Med Chem; 2010 May; 18(9):3059-65. PubMed ID: 20371186
[TBL] [Abstract][Full Text] [Related]
15. Development of a Gadolinium-Boron-Conjugated Albumin for MRI-Guided Neutron Capture Therapy.
Okada S; Nishimura K; Ainaya Q; Shiraishi K; Anufriev SA; Sivaev IB; Sakurai Y; Suzuki M; Yokoyama M; Nakamura H
Mol Pharm; 2023 Dec; 20(12):6311-6318. PubMed ID: 37909734
[TBL] [Abstract][Full Text] [Related]
16. Iodophenyl-conjugated closo-dodecaborate as a promising small boron molecule that binds to serum albumin and accumulates in tumor.
Nishimura K; Harrison S; Kawai K; Morita T; Miura K; Okada S; Nakamura H
Bioorg Med Chem Lett; 2022 Sep; 72():128869. PubMed ID: 35772634
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of a boronated nitroimidazole for boron neutron capture therapy.
Swenson DH; Laster BH; Metzger RL
J Med Chem; 1996 Mar; 39(7):1540-4. PubMed ID: 8691485
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of conjugates of polyhedral boron compounds with tumor-seeking molecules for neutron capture therapy.
Bregadze V; Semioshkin A; Sivaev I
Appl Radiat Isot; 2011 Dec; 69(12):1774-7. PubMed ID: 21531143
[TBL] [Abstract][Full Text] [Related]
19. The synthesis and use of boronated amino acids for boron neutron capture therapy.
Kabalka GW; Yao ML
Anticancer Agents Med Chem; 2006 Mar; 6(2):111-25. PubMed ID: 16529535
[TBL] [Abstract][Full Text] [Related]
20. RGD Peptide-Conjugated Dodecaborate with the Ga-DOTA Complex: A Preliminary Study for the Development of Theranostic Agents for Boron Neutron Capture Therapy and Its Companion Diagnostics.
Mishiro K; Imai S; Ematsu Y; Hirose K; Fuchigami T; Munekane M; Kinuya S; Ogawa K
J Med Chem; 2022 Dec; 65(24):16741-16753. PubMed ID: 36512639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
